Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 27, 2016
Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals
R Faria, B Woods, S Griffin, et al.
Heart (British Cardiac Society)
|
March 18, 2014
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective
A Griffiths, N Paracha, A Davies, et al.
Health Technology Assessment (Winchester, England)
|
October 23, 2009
Rimonabant for the treatment of overweight and obese people
J Burch, C McKenna, S Palmer, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|
October 13, 1999
The "Let's Get Alarmed!" initiative: a smoke alarm giveaway programme
C DiGuiseppi, S Slater, I Roberts, et al.
European Heart Journal
|
August 15, 2002
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial
M Sculpher, D Smith, T Clayton, et al.
Health Technology Assessment (Winchester, England)
|
September 27, 2005
Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis
H Epps, L Ginnelly, M Utley, et al.
Quality in Health Care : QHC
|
August 6, 1995
Managing menorrhagia
A Coulter, A Long, J Kelland, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2004
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder
C Bridle, S Palmer, A-M Bagnall, et al.
Health Technology Assessment (Winchester, England)
|
February 14, 2003
A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists
M Robinson, L Ginnelly, M Sculpher, et al.
Health Technology Assessment (Winchester, England)
|
December 21, 2007
A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery
G Cranny, R Elliott, H Weatherly, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
Alimentary Pharmacology & Therapeutics
|
August 27, 2016
Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals
R Faria, B Woods, S Griffin, et al.
Heart (British Cardiac Society)
|
March 18, 2014
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective
A Griffiths, N Paracha, A Davies, et al.
Health Technology Assessment (Winchester, England)
|
October 23, 2009
Rimonabant for the treatment of overweight and obese people
J Burch, C McKenna, S Palmer, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|
October 13, 1999
The "Let's Get Alarmed!" initiative: a smoke alarm giveaway programme
C DiGuiseppi, S Slater, I Roberts, et al.
European Heart Journal
|
August 15, 2002
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial
M Sculpher, D Smith, T Clayton, et al.
Health Technology Assessment (Winchester, England)
|
September 27, 2005
Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis
H Epps, L Ginnelly, M Utley, et al.
Quality in Health Care : QHC
|
August 6, 1995
Managing menorrhagia
A Coulter, A Long, J Kelland, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2004
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder
C Bridle, S Palmer, A-M Bagnall, et al.
Health Technology Assessment (Winchester, England)
|
February 14, 2003
A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists
M Robinson, L Ginnelly, M Sculpher, et al.
Health Technology Assessment (Winchester, England)
|
December 21, 2007
A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery
G Cranny, R Elliott, H Weatherly, et al.
Page
of 8